The Facts: Medicare Part D and Prescription Drug Prices
Source: A fact sheet jointly prepared by health policy experts from the American Enterprise Institute, the Center for Medicine in the Public Interest, the Galen Institute, The Heritage Foundation, the Institute for Policy Innovation, the Institute for Research on the Economics of Taxation, the National Center for Policy Analysis, and the Pacific Research Institute, 01/09/07
Full text: http://www.galen.org/pdrugs.asp?docID=958
Can Government Price Negotiation Work for the Medicare Drug Benefit?
American Enterprise Institute Event
Friday, January 19, 2007, 2:00 p.m. – 4:00 p.m.
Wohlstetter Conference Center, Twelfth Floor, AEI
1150 Seventeenth Street, NW, Washington, DC
Registration: www.aei.org
Medicare and the Market
Author: Mike Leavitt
Source: The Washington Post, 01/11/07
Full text: http://www.washingtonpost.com/wp-dyn/content/article/2007/01/10/AR2007011002020.html?sub=AR
Experts Fault House Bill on Medicare Drug Prices
Author: Christopher Lee
Source: The Washington Post, 01/11/07
Full text: http://www.washingtonpost.com/wp-dyn/content/article/2007/01/10/AR2007011002150.html
Hearing on Prescription Drug Pricing and Negotiation for the Medicare Prescription Drug Benefit
Author: Edmund F. Haislmaier, The Heritage Foundation
Source: U.S. Senate Committee on Finance, 01/11/07
Full text: http://www.heritage.org
The Fix is In
Author: Sally Pipes
Source: National Review Online, 01/11/07
Full text: http://www.pacificresearch.org/press/opd/2007/opd_07-01-11sp.html
We Oppose Negotiations on Medicare Part D Drug Prices
Source: The Hill, 01/10/07
Full text: http://thehill.com
Medicare Part D ? How Would the Government Negotiate?
Author: Senator Charles Grassley
Source: U.S. Senate Committee on Finance, 01/10/07
Full text: http://finance.senate.gov/press/Gpress/2007/prg010907d.pdf
Drug Program Enrollment Increases
Author: Kevin Freking
Source: Houston Chronicle, 01/10/07
Full text: http://www.chron.com/disp/story.mpl/ap/politics/4461603.html
H.R. 4, Medicare Prescription Drug Price Negotiation Act of 2007
Source: Congressional Budget Office, 01/10/07
Full text: http://www.cbo.gov/showdoc.cfm?index=7722&sequence=0&from=7
What's Wrong with Negotiations?
Author: Grace-Marie Turner
Source: Galen Institute, 01/08/07
Full text: http://www.galen.org/pdrugs.asp?docID=961
Reference Pricing without the Reference
Author: Peter Pitts
Source: Center for Medicine in the Public Interest/DrugWonks.com
Full text: http://www.drugwonks.com
No Way VA is a Better Way
Author: Peter Pitts
Source: Center for Medicine in the Public Interest
Full text: http://www.galen.org/pdrugs_cg.asp?docID=962
Federal Drug Price Negotiation: Implications for Medicare Part D
Author: Jim Hahn
Source: Congressional Research Service, 01/05/07
Full text: /assets/CRSRL33782.pdf
The Wrong Prescription for Medicare Drug Plan
Author: Yong Suh
Source: The Baltimore Sun, 01/05/07
Medicare Drug Benefit Fine As Is, Madam Speaker
Author: Grace-Marie Turner
Source: Houston Chronicle, 01/04/07
Full text: http://www.chron.com/disp/story.mpl/editorial/outlook/4447256.html
Prescription Drug Costs
Author: Benjamin Zycher
Source: The Washington Times, 12/27/06
Full text: http://washingtontimes.com/op-ed/20061226-093747-6813r.htm
Should Medicare negotiate prices? No. Private insurers are already getting discounts
Author: Robert E. Moffit, Ph.D.
Source: Philadelphia Inquirer, 12/07/06
Full text: http://www.heritage.org/Press/Commentary/ed120706d.cfm
Why the New Congress Should Not Fix Drug Prices
Author: Greg D'Angelo
Source: The Heritage Foundation, 12/01/06
Full text: http://www.heritage.org/Research/HealthCare/wm1270.cfm
A Tale of Two Drug Classes Shows Why U.S. Mustn't Go Europe's Way
Author: Paul Howard
Source: Investor's Business Daily, 12/01/06
Full text: http://www.investors.com/editorial/editorialcontent.asp?secid=1502&status=article&id=249867258301472
The Human Cost of Federal Price Negotiations: The Medicare prescription drug benefit and pharmaceutical innovation
Author: Benjamin Zycher, Ph.D.
Source: Center for Medical Progress at the Manhattan Institute, 11/06
Full text: http://www.manhattan-institute.org/html/mpr_03.htm
On Drug Prices, Are Democrats in a Fix?
Author: Ricardo Alonso-Zaldivar
Source: Los Angeles Times, 11/26/06
Success of Drug Plan Challenges Democrats
Authors: Lori Montgomery and Christopher Lee
Source: The Washington Post, 11/26/06
A Drug Price Path to Avoid
Author: Alberto Mingardi
Source: The Washington Post, 11/12/06
Full text: http://www.washingtonpost.com/wp-dyn/content/article/2006/11/10/AR2006111001489.html
Should the U.S. Government be Prohibited from Negotiating with Drug Companies?
Guest: Peter Pitts
Source: The Bauer and Rose Show, 11/14/06
Listen online: http://www.bauerandrose.com/show?action=viewRadioShow&showID=518
Competition Works
Author: Grace-Marie Turner
Source: Galen Institute, 11/2/06
Full text: http://www.galen.org/medicare.asp?docID=933
The Dangers of Undermining Patient Choice:
Lessons from Europe and Canada
Source: Institute for Policy Innovation, Galen Institute, and International Policy Network, 10/06
Full text: http://www.galen.org/healthabroad.asp?docID=929
The Praises and Pitfalls of Part D
Author: Grace-Marie Turner
Source: The Kansas City Star, 10/29/06
Full text: http://www.galen.org/medicare.asp?docID=933
Medicare Part D: Improving Care for Beneficiaries Without Drug Coverage
Source: PhRMA, 10/27/06
The Future of Medicare
Author: Robert Goldberg, Ph.D.
Source: The Washington Times, 10/17/06
Full text: http://www.washingtontimes.com/op-ed/20061016-100753-7317r.htm
Debunking Medicare Myths
Author: Grace-Marie Turner
Source: Galen Institute, 9/15/06
Full text: http://www.galen.org/medicare.asp?docID=920
Lawsuit Ignores Who?s Gouging Whom on Drug Prices
Author: John R. Graham
Source: Pacific Research Institute, 09/02/05
Full text: http://www.pacificresearch.org/press/opd/2005/opd_05-09-02jg.html